(Q38168707)

30 August 2017

Improved clinical control of a challenging case of Behçet's disease with rituximab therapy (English)

1 reference

30 August 2017

0 references

1 reference

Barbara Hong Zhao

1

1 reference

PubMed ID

24305944

30 August 2017

Anna Elfiky Oswald

series ordinal

2

1 reference

30 August 2017

4 December 2013

1 reference

30 August 2017

Clinical Rheumatology

1 reference

30 August 2017

33

1 reference

30 August 2017

1

1 reference

30 August 2017

149-150

1 reference

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

30 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

The use of biologic agents in the treatment of ocular manifestations of Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

Mononeuritis multiplex in incomplete Behçet's disease: a case report and the review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

Treatment of retinal vasculitis in Behçet's disease with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

Clinicopathologic evaluation of nodular cutaneous lesions of Behçet syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

Effect of infliximab in progressive neuro-Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

Development of Immunopathogenesis Strategies to Treat Behçet's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2433-X

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

21 January 2018

1 reference

12 December 2020

How to recognise and treat peripheral nervous system vasculitis

1 reference

12 December 2020

Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies.

1 reference

12 December 2020

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

12 December 2020

10.1007/S10067-013-2433-X

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24305944